Caring About Cancer Patients
"Memoirs of Cancer" Book Now Available - Caring About Cancer Patients
RSS Follow

Delivered by FeedBurner

Recent Posts

PANCREAS CANCER NEWS
Cervical Cancer is an International Issue
Cancer Death Rates Declining But Disparity for African Americans Still Exist
Danstock: 4 Bands 2 Raise $ 4 Cancer Research
Is a Clinical Trial Right for You?

Most Popular Posts

Sugar considered a culprit in cancer cases
Secondary Liver Cancer
The Virus HLTV-1 and Cancer
Herbs That Can Help Cancer Patients-PERIWINKLE
Antipsychotic Drug Controls "Breakthrough" Nausea and Vomiting after Chemotherapy

Categories

African American
Anal Cancer
Bladder Cancer
Brain Cancer
Breast Cancer
Breast Cancer Awareness Month
Cancer and Fertility
CANCER AND OBESITY
Cancer and Stem Cells
Cancer Care/Self-Help
CANCER EVENTS
Cancer Facts/Statistics
Cancer Information/Updates
Cancer Loss
Cancer Memories
Cancer Prevention
cancer research
Causes of cancer
Cervical cancer
Chemotherapy
Children and cancer
Clinical Trials for Cancer
colon cancer
COLORECTAL CANCER
Exciting
Head and Neck Cancer
Health Care Disparities
Help for Cancer Patient Caregivers
JOB TRAINING
Liver Cancer
LUNG CANCER
Melanoma
Metastatic Cancer
Multicultural
Multiple Myeloma Cancer
New Cancer Info.
ovarian cancer
Pancreatic Cancer
Pancreatic Cancer Awareness Month
PROSTATE CANCER
Stomach Cancer
TRIPLE NEGATIVE BREAST CANCERS

Archives

April 2013
February 2013
January 2013
December 2012
November 2012
October 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011

powered by

Caring About Cancer Patients

December 2011

Combination Therapy Shows Promise for Treating Advanced Breast Cancer

NCI: Posted on Saturday, December 31, 2011 5:37 PM
Adding the drug everolimus (Afinitor) to exemestane helped postmenopausal women whose advanced breast cancer had stopped responding to hormonal therapy live about 4 months longer without the disease progressing than women who received exemestane alone. Findings from the trial, called BOLERO 2, were presented last week at the San Antonio Breast Cancer Symposium

.For women who received the combination therapy, the median progression-free survival
Categories: Cancer Information/Updates, Breast Cancer, Metastatic Cancer, cancer research
Trackback Link

Prostate Cancer Trials Show No Link between Androgen-Deprivation Therapy and Cardiac Deaths

NCI: Posted on Sunday, December 18, 2011 9:08 PM
Several studies have suggested that men who receive androgen-deprivation therapy (ADT) to treat prostate cancer may face an increased risk of dying from cardiovascular causes. But a new analysis of clinical trial results has found no evidence that ADT increases cardiovascular deaths among men with high-risk, nonmetastatic prostate cancer.
 
The findings, from a meta-analysis of eight randomized clinical trials, appeared in the December 7 issue ofJAMA. Androgen-deprivation therapy, which suppresses the production of male hormones, is a mainstay of prostate cancer care.
Categories: New Cancer Info., PROSTATE CANCER
Trackback Link

Two Drugs that Hit One Target Show Efficacy against Metastastic Breast Cancer

NCI/ Nwaokai: Posted on Wednesday, December 14, 2011 12:24 AM
Combining two drugs that target the HER2 protein, trastuzumab (Herceptin) and the investigational agentpertuzumab, with chemotherapy may be a new treatment option for women with HER2-positive metastatic breast cancer, according to results from a large clinical trial.

The phase III CLEOPATRA trial showed that combining both of the HER2-targeting agents with the chemotherapy drug docetaxel as an initial treatment led to a 6-month improvement in progression-free survival
Categories: New Cancer Info., Breast Cancer, Metastatic Cancer, cancer research
Trackback Link

Combination Therapy Shows Promise for Treating Advanced Breast Cancer

NCI: Posted on Wednesday, December 14, 2011 12:07 AM
Adding the drug everolimus (Afinitor) to exemestane helped postmenopausal women whose advanced breast cancer had stopped responding to hormonal therapy live about 4 months longer without the disease progressing than women who received exemestane alone. Findings from the trial, called BOLERO 2, were presented last week at the San Antonio Breast Cancer Symposium.

For women who received the combination therapy, the median progression-free survival
Categories: New Cancer Info., Breast Cancer, cancer research
Trackback Link

Late Effects May Not Warrant Adding Radiation to Chemotherapy for Early-Stage Hodgkin Lymphoma

NCI: Posted on Tuesday, December 13, 2011 11:55 PM
Patients with early-stage Hodgkin lymphoma who were treated with multi-drug chemotherapy alone were more likely to be alive 12 years later than patients who received the same chemotherapy plus radiation therapy, according to findings from a phase III clinical trial. More patients who received radiation therapy in addition to chemotherapy died of second cancers or other toxic late effects of their treatment, such as heart disease, than those who received chemotherapy alone, researchers 
Categories: Cancer Facts/Statistics, Cancer Information/Updates
Trackback Link

Maggie Daley "Gratitude Makes Every Day A Gift"

Lurie Cancer Center: Posted on Monday, December 05, 2011 11:33 PM
Maggie Daley "Gratitude makes everyday a gift"Steven T Rosen, MD, Director of the Lurie Cancer Center, recalls with admiration, "Maggie faced her heroic battle with breast cancer with grace and dignity. She is an inspiration for all of humanity." 

"Maggie proved that faith and strength of character can rise above adversity," says Northwestern University trustee and philanthropist, Ann Lurie. "Her tenacious battle with cancer on the one hand and her determination to continue with her public and private life on the other, have provided inspiration to many.
Categories: Cancer Care/Self-Help, Cancer Information/Updates
Trackback Link

Northwestern Integrative Medicine

Posted on Monday, December 05, 2011 11:29 PM
Northwestern Integrative Medicine combines conventional and complementary therapies to aid in the healing process. It engages the mind, body, spirit and community and focuses on lifestyle choices. Whether your cancer was recently diagnosed or is currently in remission, the potential benefits of the integrative healing approach are varied and significant. The program is run by Melinda Ring, MD, of the Northwestern Memorial Physicians Group. 

Patients receiving cancer care at Northwestern are eligible for a total of two appointments free of charge (with a referral from your oncology provider).
Categories: Cancer Information/Updates
Trackback Link
Home | About The Book | Purchase the Book | Slide Show | Book Excerpts | Events | More Videos | Contact Us | Author Radio Broadcast | The Passion Page | Cancer Survival Means... | TRANSLATION PAGE | Cancer Resources | Tribute Page | News From Susan G. Komen | Blog | RECENT DEVELOPMENTS IN CANCER